Cancer Profiling Market Worth US$ 8.74 Billion in 2022 Growing at 10.7% CAGR

Global cancer/tumor profiling market is projected to reach USD 8.74 billion in 2022 from USD 5.26 billion in 2017 at CAGR of 10.7%.The cancer/tumor profiling market is primarily driven by the increasing number of cancer cases, growing utility of biomarkers in tumor profiling, and availability of funding for cancer research.

Download Sample Copy of Cancer Profiling Market spread across 155 Pages, Profiling 11 Companies and Supported with 67 Tables and 32 Figures is now available at http://www.rnrmarketresearch.com/contacts/request-sample?rname=117219 .

Cancer profiling market in this report is segmented by cancer type, application, technology, and region. On basis of cancer type, cancer type market is categorized into breast cancer, lung cancer, colorectal cancer, prostate cancer, melanoma, & cancer types. In 2017, breast cancer segment is expected to account for largest share of global cancer/tumor profiling market.

Cancer/Tumor Profiling Market, By Technology
1 Introduction
2 Immunoassays
3 Hybridization
4 PCR
5 In Situ Hybridization (ISH)
6 DNA/RNA Microarray
7 Next Generation Sequencing
8 Mass Spectrometry

Cancer/Tumor Profiling Market, By Cancer Type
1 Introduction
2 Breast Cancer
3 Lung Cancer
4 Colorectal Cancer
5 Prostate Cancer
6 Melanoma Cancer

Global cancer profiling market broadly divided into immunoassays, hybridization, NGS, mass spectrometry, & other technologies. In 2017, immunoassays segment is expected to account for largest share of cancer profiling technologies market. High sensitivity & cost-effectiveness of these techniques and technological advancements in these immunoassays tests are factors that are expected to propel growth of this market in coming years.

Access More Information on Cancer Profiling Market with Top Trends, Forecast, Analysis and Overview at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=117219 .

Major players operating in cancer profiling market include Illumina (US), QIAGEN (Netherlands), NeoGenomics Laboratories (US), HTG Molecular Diagnostic (US), and Genomic Health (US). These players focus on inorganic strategies like acquisitions, agreements, & collaborations and organic strategies like product launches & expansions to sustain their growth in cancer profiling market.

Company Profiles
1 Illumina, Inc.
2 Qiagen N.V.
3 Neogenomics Laboratories, Inc.
4 HTG Molecular Diagnostics, Inc.
5 Genomic Health Inc.
6 Caris Life Sciences
7 Helomics Corporation
8 Nanostring Technologies, Inc.
9 Oxford Gene Technology
10 Ribomed Biotechnologies, Inc.

Click now for more information on this research of “Cancer/Tumor Profiling Market by Application (Clinical, Research), Technology (Immunoassay, Hybridization (PCR, In Situ Hybridization, DNA/RNA Microarray), NGS, Mass Spectrometry), Cancer Type (Breast, Lung, Prostate, Colorectal) - Global Forecast to 2022” report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=117219 .

Objectives of the Study
• To define, describe, and forecast the cancer/tumor profiling market on the basis of application, technology, cancer type, and region.
• To provide a detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges).
• To strategically analyze micromarkets with respect to individual growth trends, prospects, and contribution to the total market.
• To analyze the opportunities in the market for stakeholders and details of a competitive landscape for market leaders.
• To forecasting the revenue of market segments with respect to four main geographies (along with countries), namely, North America, Europe, Asia Pacific, and the RoW.
• To profile key players and comprehensively analyze their market shares and core competencies.
• To track and analyze competitive developments such as collaborations, new product developments, product enhancements, and R&D activities in the cancer/tumor profiling market.

Contact:
sales@rnrmarketresearch.com / Call +1 888 391 5441
RnRMarketResearch Provides you the further information and more details with intelligence needs for your business. Access to in-depth market trends helps companies to assess the market effectiveness.

Tower B5, Office 101,
Magarpatta City SEZ,
Pune-411013, India

This release was published on openPR.